Seres Therapeutics, Inc.
€6.513
EUR
Last updated on --.
24h volume25.62K
24h highest6.7072 EUR
24h lowest6.4750 EUR
24h Price movement-0.20%
MCRB recent prices
24 Hours
-0.20%-€0.012899
30 days
+8.25%+€0.50304
60 days
-12.78%-€0.96739
90 days
-12.19%-€0.91579
Key data
Previous close6.5266 EUR
Market cap63.79M EUR
Volume25.62K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.1619 EUR
Net income (FY)-40.33M EUR
Revenue (FY)986.31K EUR
Last report dateMay 5, 2026
About Seres Therapeutics, Inc.
HeadquartersCAMBRIDGE
Employees (FY)66.00
Revenue per employee (FY)14.94K EUR
Net income per employee (FY)-611.04K EUR
Listed onNasdaq
MCRB conversion tables
 |  |
|---|---|
| 0.5 MCRB | 3.256 EUR |
| 1 MCRB | 6.513 EUR |
| 5 MCRB | 32.56 EUR |
| 10 MCRB | 65.13 EUR |
| |
|---|---|
| 0.5 EUR | 0.076761 MCRB |
| 1 EUR | 0.15352 MCRB |
| 5 EUR | 0.76761 MCRB |
| 10 EUR | 1.535 MCRB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
MCRB is trading at €6.513, -0.20% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MCRB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MCRB is currently trading at €6.513, -0.20% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MCRB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MCRB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MCRB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MCRB's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Seres Therapeutics, Inc.'s market cap is currently 63.79M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume25.62K
24h highest6.7072 EUR
24h lowest6.4750 EUR
24h Price movement-0.20%
Start trade with MCRB Perpetual
Sign up to trade